Clinical trial
Influenza Vaccine in Premature Infants
NCT00455169 · University of Rochester, Other · Completed
Key facts
| NCT number | NCT00455169 |
|---|---|
| Title | Influenza Vaccine in Premature Infants |
| Official title | Influenza Vaccine Immunogenicity in Extremely Premature Infants |
| Lead sponsor | University of Rochester, Other |
| Collaborators | Thrasher Research Fund University of Miami Wake Forest University Health Sciences State University of New York at Buffalo University of Texas Southwestern Medical Center |
| Status | Completed |
| Study type | Observational |
| Conditions | Influenza, Infant, Premature |
| Intervention type | Biological |
| Interventions | Trivalent Inactivated Influenza Vaccine |
| Enrollment | 66 |
| Start date | Oct 1, 2007 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Apr 3, 2007 |
| Last update posted | Sep 17, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: